IMMUNITYBIO, INC. Revenue Breakdown
No Revenue Breakdown for IBRX on this site yet.
- 2025-12-31: Others Not split by product in the filing$113.29M100.00%; Total revenue $113.29M.
- 2024-12-31: Others Not split by product in the filing$14.74M100.00%; Total revenue $14.74M.
- 2023-12-31: Others Not split by product in the filing$622.00K100.00%; Total revenue $622.00K.
- 2022-12-31: Total revenue $240.00K.
Source checked: the stored Revenue Breakdown page for IBRX.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $113.29M 100.00% | $113.29M |
| 2024-12-31 | Not split by product in the filing $14.74M 100.00% | $14.74M |
| 2023-12-31 | Not split by product in the filing $622.00K 100.00% | $622.00K |
| 2022-12-31 | $240.00K | |
| 2021-12-31 | Not split by product in the filing $934.00K 100.00% | $934.00K |
| 2020-12-31 | Not split by product in the filing $605.00K 100.00% | $605.00K |
| 2019-12-31 | Not split by product in the filing $2.20M 100.00% | $2.20M |
| 2018-12-31 | $47.00K | |
| 2017-12-31 | $45.00K | |
| 2016-12-31 | $44.00K | |
| 2015-12-31 | $236.00K | |
| 2014-12-31 | Not split by product in the filing $641.00K 100.00% | $641.00K |
| 2013-12-31 | Not split by product in the filing $600.00K 100.00% | $600.00K |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $51.24M 100.00% | $51.24M |
| 2026-03-31 | Not split by product $44.21M 100.00% | $44.21M |
| 2025-12-31 | Not split by product $38.28M 100.00% | $38.28M |
| 2025-09-30 | Not split by product $32.06M 100.00% | $32.06M |
| 2025-06-30 | Not split by product $26.43M 100.00% | $26.43M |
| 2025-03-31 | Not split by product $16.52M 100.00% | $16.52M |
| 2024-12-31 | Not split by product $7.55M 100.00% | $7.55M |
| 2024-09-30 | Not split by product $6.11M 100.00% | $6.11M |
| 2024-06-30 | Not split by product $1.05M 100.00% | $1.05M |
| 2024-03-31 | Not split by product $40.00K 100.00% | $40.00K |
| 2023-12-31 | Not split by product $139.00K 100.00% | $139.00K |
| 2023-09-30 | Not split by product $82.00K 100.00% | $82.00K |
| 2023-06-30 | Not split by product $41.00K 100.00% | $41.00K |
| 2023-03-31 | Not split by product $360.00K 100.00% | $360.00K |
| 2022-12-31 | Not split by product $73.00K 100.00% | $73.00K |
| 2022-09-30 | Not split by product $118.00K 100.00% | $118.00K |
| 2022-06-30 | Not split by product $35.00K 100.00% | $35.00K |
| 2022-03-31 | Not split by product $14.00K 100.00% | $14.00K |
| 2021-12-31 | Not split by product $390.00K 100.00% | $390.00K |
| 2021-09-30 | Not split by product $66.00K 100.00% | $66.00K |
| 2021-06-30 | Not split by product $339.00K 100.00% | $339.00K |
| 2021-03-31 | Not split by product $139.00K 100.00% | $139.00K |
| 2020-12-31 | Not split by product $21.00K 100.00% | $21.00K |
| 2020-09-30 | Not split by product $151.00K 100.00% | $151.00K |
| 2020-06-30 | Not split by product $436.00K 100.00% | $436.00K |
| 2020-03-31 | Not split by product $165.00K 100.00% | $165.00K |
| 2019-12-31 | Not split by product $9.00K 100.00% | $9.00K |
| 2019-09-30 | Not split by product $12.00K 100.00% | $12.00K |
| 2019-06-30 | Not split by product $17.00K 100.00% | $17.00K |
| 2019-03-31 | Not split by product $5.00K 100.00% | $5.00K |
| 2018-12-31 | Not split by product $7.00K 100.00% | $7.00K |
| 2018-09-30 | Not split by product $31.00K 100.00% | $31.00K |
| 2018-06-30 | Not split by product $4.00K 100.00% | $4.00K |
| 2018-03-31 | Not split by product $5.00K 100.00% | $5.00K |
| 2017-12-31 | Not split by product $12.00K 100.00% | $12.00K |
| 2017-09-30 | Not split by product $8.00K 100.00% | $8.00K |
| 2017-06-30 | Not split by product $14.00K 100.00% | $14.00K |
| 2017-03-31 | Not split by product $11.00K 100.00% | $11.00K |
| 2016-12-31 | Not split by product $14.00K 100.00% | $14.00K |
| 2016-09-30 | Not split by product $12.00K 100.00% | $12.00K |
| 2016-06-30 | Not split by product $12.00K 100.00% | $12.00K |
| 2016-03-31 | Not split by product $6.00K 100.00% | $6.00K |
| 2015-12-31 | Not split by product $15.00K 100.00% | $15.00K |
| 2015-09-30 | Not split by product $10.00K 100.00% | $10.00K |
| 2015-06-30 | Not split by product $91.00K 100.00% | $91.00K |
| 2015-03-31 | Not split by product $120.00K 100.00% | $120.00K |
| 2014-12-31 | Not split by product $98.00K 100.00% | $98.00K |
| 2014-09-30 | Not split by product $133.00K 100.00% | $133.00K |
| 2014-06-30 | Not split by product $124.00K 100.00% | $124.00K |
| 2014-03-31 | Not split by product $286.00K 100.00% | $286.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |